What is the initial management of sepsis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Initial Management of Sepsis

Begin immediate resuscitation with at least 30 mL/kg IV crystalloid fluid within the first 3 hours and administer broad-spectrum IV antimicrobials within 1 hour of recognition. 1, 2, 3

Immediate Actions (Within 1 Hour)

Fluid Resuscitation

  • Administer at least 30 mL/kg of IV crystalloid fluid within the first 3 hours for patients with sepsis-induced hypoperfusion (hypotension or lactate >4 mmol/L) 1, 2, 3
  • Use crystalloids (balanced solutions or normal saline) as the first-choice fluid, avoiding hydroxyethyl starches which increase acute kidney injury and mortality 4, 1, 3
  • Continue fluid administration using a challenge technique (boluses of 1000 mL crystalloids or 300-500 mL colloids over 30 minutes), giving additional fluids as long as hemodynamic parameters continue to improve 4, 3
  • Consider adding albumin when patients require substantial amounts of crystalloids (typically after initial crystalloid resuscitation) 4, 3

Antimicrobial Therapy

  • Administer IV antimicrobials within 1 hour of recognition for both sepsis and septic shock 4, 1, 2, 3
  • Obtain at least two sets of blood cultures (aerobic and anaerobic) before starting antimicrobials if this causes no significant delay (>45 minutes) 4, 2
  • Use empiric broad-spectrum therapy covering all likely pathogens (bacterial, and potentially fungal or viral) based on clinical syndrome, patient history, and local epidemiology 4, 2, 5

Hemodynamic Monitoring

  • Measure lactate levels at the time of sepsis diagnosis and repeat within 6 hours if initially elevated (>2 mmol/L) 1, 2, 3
  • Target a mean arterial pressure (MAP) of 65 mmHg in patients requiring vasopressors 4, 1, 2, 3
  • Monitor heart rate, blood pressure, arterial oxygen saturation, respiratory rate, temperature, urine output, capillary refill, skin mottling, and mental status 2

Resuscitation Goals (First 3-6 Hours)

Hemodynamic Targets

  • Central venous pressure (CVP) 8-12 mmHg (12-15 mmHg if mechanically ventilated or decreased ventricular compliance) 4
  • Mean arterial pressure ≥65 mmHg 4
  • Urine output ≥0.5 mL/kg/hour 4
  • Central venous oxygen saturation (ScvO2) ≥70% or mixed venous oxygen saturation (SvO2) ≥65% 4

Vasopressor Therapy

  • Initiate vasopressors if hypotension persists despite adequate fluid resuscitation, targeting MAP ≥65 mmHg 4, 3
  • Use norepinephrine as the first-choice vasopressor 4, 1, 3
  • Add epinephrine when an additional agent is needed to maintain adequate blood pressure 4, 1, 3
  • Vasopressors can be administered peripherally if central access is not immediately available, as peripheral use has been deemed safe 6

Source Control

  • Identify or exclude a specific anatomic diagnosis of infection requiring emergent source control as rapidly as possible 4, 1, 2, 3
  • Implement required source control intervention (drainage, debridement) as soon as medically and logistically practical, ideally within 12 hours of diagnosis 4, 3
  • Remove intravascular access devices promptly if they are a possible source after establishing alternative vascular access 4, 3

Ongoing Management

Fluid Reassessment

  • Use dynamic measures of fluid responsiveness (pulse pressure variation, stroke volume variation) over static measures (CVP) when available 4, 1
  • Reassess hemodynamic status frequently through clinical examination and physiologic variables 1, 2, 3
  • Avoid fluid overresuscitation, which can delay organ recovery, prolong ICU stay, and increase mortality 3

Antimicrobial Optimization

  • Reassess antimicrobial regimen daily for potential de-escalation once pathogen identification and sensitivities are established 4, 3
  • Consider procalcitonin levels to support discontinuation of empiric antibiotics in patients with limited clinical evidence of infection 4, 3
  • Duration of therapy typically 7-10 days, with longer courses for slow clinical response, undrainable foci, S. aureus bacteremia, or immunodeficiency 4

Additional Interventions

  • Apply oxygen to achieve saturation >90% 2
  • Place patients in semi-recumbent position (head of bed raised 30-45°) 2
  • **Consider transfusion if ScvO2 remains <70% despite fluids and vasopressors**, targeting hemoglobin >10 g/dL in the context of septic shock 4

Critical Pitfalls to Avoid

  • Do not delay antimicrobials beyond 1 hour - consider intraosseous access or intramuscular administration if vascular access is difficult 3
  • Do not rely solely on CVP to guide fluid therapy - use dynamic measures and clinical assessment instead 3, 6
  • Do not use hydroxyethyl starches - they increase acute kidney injury and mortality 4, 1, 3
  • Do not give antimicrobials to patients with severe inflammatory states determined to be of noninfectious cause 4, 3
  • Do not apply the standard 30 mL/kg fluid bolus rigidly - patients with low ejection fraction may require smaller boluses with more frequent reassessment and earlier vasopressor initiation 3

References

Guideline

Sepsis Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Sepsis Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Septic Shock

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

An approach to antibiotic treatment in patients with sepsis.

Journal of thoracic disease, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.